Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells
about
Highlight: BRCA1 and BRCA2 proteins in breast cancerScrib regulates PAK activity during the cell migration processThe PI3K-PDK1 connection: more than just a road to PKBActivation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damageAkt kinases in breast cancer and the results of adjuvant therapyPhosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activityDirect interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cellsMolecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.Peptide and protein library screening defines optimal substrate motifs for AKT/PKB.Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells.Akt activation emulates Chk1 inhibition and Bcl2 overexpression and abrogates G2 cell cycle checkpoint by inhibiting BRCA1 fociTargeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization.Akt: a double-edged sword in cell proliferation and genome stability.Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers.JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.An essential role for protein synthesis in oncogenic cellular transformation.Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1AKT regulates BRCA1 stability in response to hormone signaling.The emerging role of the PI3-K-Akt pathway in prostate cancer progression.Targeting the epigenetics of the DNA damage response in breast cancer.AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma.Nuclear and mitochondrial signalling Akts in cardiomyocytesThe efficacy of Herceptin therapies is influenced by the expression of other erbB receptors, their ligands and the activation of downstream signalling proteinsReversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination SystemBRCA1 16 years later: nuclear import and export processes.Opportunities and hurdles in the treatment of BRCA1-related breast cancer.An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.Bone marrow-derived mesenchymal stem cells up-regulate acetylcholine receptor delta subunit through NRG/ErbB3-mediated mitogen-activated protein kinase pathway.Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival.Hyperphosphorylation of the BARD1 tumor suppressor in mitotic cells.Novel role for cyclin-dependent kinase 2 in neuregulin-induced acetylcholine receptor epsilon subunit expression in differentiated myotubes.Akt promotes tumorigenesis in part through modulating genomic instability via phosphorylating XLF.BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity.Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cellsCharacterization of dual PTEN and p53-targeting microRNAs identifies microRNA-638/Dnm2 as a two-hit oncogenic locus.
P2860
Q24307401-6D4A5A9F-1978-46D7-8425-386DDA52CD49Q24328751-7E89A62A-3514-4D84-BEA7-789B487FCA21Q24531972-30F48DF2-0D00-43B7-8AF3-3714E64B1E89Q24537734-FE0E14C9-78B1-46C7-A215-6AC4F4515639Q24795435-087165A6-4A48-4F8E-8F9C-5057A2F484E6Q24801684-59DB4F2E-DA3B-457A-A9B2-B02780B9FC01Q28204976-80052367-84ED-4ABA-89AD-8937BD2A5AAFQ28210850-181C9B04-7C2E-4270-86D7-55C35BEA4D53Q28566353-BA0BA456-1B26-4483-A454-38BB5AF2EBD5Q30459589-557D25D4-449D-4B2A-A049-BE7BEFE05B8BQ30652695-C314DC47-BB3C-4DFD-9C5B-B62B7CFC3953Q33627677-8FE970A1-4811-417F-BADB-4A1EBD515AD8Q33784347-0B8C5454-37D8-46DE-ACCF-2F9DE1AFE21FQ34025378-C0039FA1-A26B-48E7-92B8-0E7A8B158253Q34138796-1FBD14A8-52E5-41F4-98E5-6643B4CCD858Q34223641-77E6098E-2CCC-46D4-81EA-9B0DD4724A2AQ35071151-A52BC252-C84F-4638-915F-C6AC700449A7Q35169608-376AB751-A8CE-4876-8BC5-D89DDA97400CQ35635353-7E73AC02-78B0-4D36-B8B1-2C32B3C6A081Q35750105-4627CC80-5DD9-43B1-961F-DECFD9A28976Q35924811-33E303B2-CF68-4548-BF0F-38298555F1BBQ35994422-7665252B-862D-426E-A3A2-2782CEED11C2Q36050987-E43BC265-7E9A-4F5D-B370-26C05ED19DA4Q36866453-73872791-21A6-4C35-BC9D-631DCCF0FD1FQ37045823-55363993-C28F-499E-A346-B78E455FF03AQ37176193-1AAE216E-B37B-4280-A152-8964CE389EC1Q37355431-5E5A155C-1FB7-4AA0-925E-B0679C2CF53BQ37611723-69B1AD31-3465-4D66-AC8E-1628CCB3C79BQ37770592-2BDBDF97-6938-48D2-8907-D19148621BA7Q38129725-71CAFB30-2C23-49A7-BE8F-FE66AA8E5B8AQ39365992-60371B31-EE22-463F-842B-6611CDDB971CQ39388270-20B34F1B-3648-4AB8-B59B-9A3295E4D9CDQ39739693-988E78F4-66DE-4B9D-84D9-70481346036BQ40301535-5E49C532-7194-44CC-8AD4-1BD09E4FA689Q40430437-95FC598A-EF72-422F-80C0-DFB286FB9EE2Q40436456-8BAC199C-DC57-44B2-B0D4-C1DDE60FF107Q40678340-3D37EF38-A72A-4099-A77B-47B477C799C1Q40686292-DCA400B8-3CC2-472B-A4ED-EE1E9FE3C91BQ40736171-A71ACD6F-4A3C-4E22-8D73-2D5E3C13AE61Q41912362-A14BDD6C-8A1E-4448-AE33-0E864A12C488
P2860
Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@ast
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@en
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@nl
type
label
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@ast
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@en
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@nl
prefLabel
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@ast
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@en
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@nl
P2093
P2860
P3181
P356
P1476
Heregulin induces phosphorylat ...... ase/AKT in breast cancer cells
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.274.45.32274
P407
P577
1999-11-05T00:00:00Z